U2Bio Co (XKRX:221800) FCF Yield % : -6.95 (As of May. 26, 2024)

View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, U2Bio Co's Trailing 12-Month Free Cash Flow is ₩-3,532 Mil, and Market Cap is ₩50,792 Mil. Therefore, U2Bio Co's FCF Yield % for today is -6.95%.

The historical rank and industry rank for U2Bio Co's FCF Yield % or its related term are showing as below:

XKRX:221800' s FCF Yield % Range Over the Past 10 Years
Min: -9.83 Med: -0.98 Max: 19.39
Current: -6.95

During the past 9 years, the highest FCF Yield % of U2Bio Co was 19.39%. The lowest was -9.83%. And the median was -0.98%.

XKRX:221800's FCF Yield % is ranked worse than
57.76% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.815 vs XKRX:221800: -6.95

U2Bio Co's FCF Margin % for the quarter that ended in Dec. 2023 was 9.62%.

U2Bio Co FCF Yield % Historical Data

The historical data trend for U2Bio Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co FCF Yield % Chart

U2Bio Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-5.97

6.90

16.60

35.50

-5.93

U2Bio Co Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
FCF Yield %	13.66	55.99	-10.40	4.49

Competitive Comparison of U2Bio Co's FCF Yield %

For the Diagnostics & Research subindustry, U2Bio Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U2Bio Co's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where U2Bio Co's FCF Yield % falls into.

U2Bio Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

U2Bio Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-3532.491	/	59596.416
	=	-5.93%

U2Bio Co's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	1337.307	*	2	/	59596.416
	=	4.49%

U2Bio Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

U2Bio Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of U2Bio Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

U2Bio Co (XKRX:221800) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Basement 1, 68 Gumaro Songpagu, Seoul, KOR

Website

http://www.u2bio.co.kr

U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines